At a glance

Roche continues driving one of this industry’s best product pipelines. In 2019, we invested about one fifth of the company’s sales to develop new tests and medicines for patients in need of new options. A leader in oncology, we are now also entering new disease areas with very low incidence rates. These include multiple sclerosis, haemophilia and neuroscience disesases.

Did you know?

Xổ số miền nam thứ 7 tuần trướcOur Global Access Program has had a major positive impact on diagnosing HIV in low- and middle-income countries. Since 2014, over 14 million HIV diagnostic tests have reached 82 countries eligible for access.

In 2019, the programme was expanded to include tests for HIV-1 viral load, HIV-1 and HIV-2 early infant diagnosis, tuberculosis, hepatitis B and C, and HPV.

Achievements

We significantly expanded our range of tests with several launches and approvals. Our broad portfolio, the industry’s most comprehensive, enables clinical decision-making and personalised healthcare. In conjunction with a high number of instruments installed globally, this makes us an ideal partner for healthcare providers and industry.

billion tests conducted with Roche products in 2019

100 k

Xổ số miền nam thứ 7 tuần trước Roche Diagnostics has a total of more than 100'000 instruments installed in laboratories, worldwide

A glimpse into the future

Our integrated diagnostic solutions are designed to meet the challenges of today even as we anticipate the needs of tomorrow. They also simplify the complexity that laboratory professionals and healthcare organisations face every day, helping to improve patient outcomes in a rapidly changing healthcare environment.

million patients treated

expedited reviews for Roche medicines

“I work in Procurement at Roche Diagnostics in Penzberg and I am responsible for correct invoicing and punctual payment of suppliers. I was diagnosed with multiple sclerosis (MS) when I was 16. The disease has progressed gradually and so my team and I have always had the time to adapt to new situations.

At first, I had difficulty in walking but I could still drive to work myself. Then I had to start using a walking frame. For the last few years, I have been using a wheelchair and coming to work by taxi. My colleagues are always supportive—they hold doors open, take my work equipment to meetings and help me to put my coat on. Even push my wheelchair.

Xổ số miền nam thứ 7 tuần trướcDue to MS, my work has changed over the years. Initially, I headed a sub-department within Procurement. I cannot do this job anymore as my disease has progressed. My line managers and I redefine my range of duties if needed. Over time, I come to terms with my new roles more easily. It is important to me that I can keep contributing to the company’s success with my work.“

Marion Knöring works at Roche Diagnostics in Penzberg, Germany

89 %

Xổ số miền nam thứ 7 tuần trước of employees believe that their work has a positive impact on society

83 %

of employees are happy
to work at Roche

Roche Rotkreuz, Switzerland

Learn more

tbc-metal.com/investors

Our Strategy

tbc-metal.com/about/our-strategy

Join Roche

tbc-metal.com/careers

Share it out

[STORY_SWIPE_LABEL]

Xổ số miền nam thứ 7 tuần trướcPlease rotate your device

At a glance

Patient Story

Did you know?

Patient Story

Achievements

A glimpse into the future

Patient Story

People Story

At a glance

Patient Story

Did you know?

Patient Story

Achievements

A glimpse into the future

Patient Story

People Story

Share this page via